214 related articles for article (PubMed ID: 34304944)
1. The mucosal immune system of the upper respiratory tract and recent progress in mucosal vaccines.
Kurono Y
Auris Nasus Larynx; 2022 Feb; 49(1):1-10. PubMed ID: 34304944
[TBL] [Abstract][Full Text] [Related]
2. Intranasal immunization with phosphorylcholine induces antigen specific mucosal and systemic immune responses in mice.
Tanaka N; Fukuyama S; Fukuiwa T; Kawabata M; Sagara Y; Ito HO; Miwa Y; Nagatake T; Kiyono H; Kurono Y
Vaccine; 2007 Mar; 25(14):2680-7. PubMed ID: 17270319
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylcholine intranasal immunization with a 13-valent pneumococcal conjugate vaccine can boost immune response against Streptococcus pneumoniae.
Ohori J; Iuchi H; Maseda Y; Kurono Y
Vaccine; 2020 Jan; 38(3):699-704. PubMed ID: 31668823
[TBL] [Abstract][Full Text] [Related]
4. Mucosal and systemic immune response to sublingual or intranasal immunization with phosphorylcholine.
Maseda Y; Ohori J; Tanaka N; Nagano H; Miyashita K; Kurono Y
Auris Nasus Larynx; 2018 Apr; 45(2):273-280. PubMed ID: 28478921
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
Kataoka K; Fukuyama Y; Briles DE; Miyake T; Fujihashi K
Microbiol Immunol; 2017 Jun; 61(6):195-205. PubMed ID: 28463465
[TBL] [Abstract][Full Text] [Related]
6. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections.
Jakobsen H; Schulz D; Pizza M; Rappuoli R; Jónsdóttir I
Infect Immun; 1999 Nov; 67(11):5892-7. PubMed ID: 10531245
[TBL] [Abstract][Full Text] [Related]
7. Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae.
Kong IG; Sato A; Yuki Y; Nochi T; Takahashi H; Sawada S; Mejima M; Kurokawa S; Okada K; Sato S; Briles DE; Kunisawa J; Inoue Y; Yamamoto M; Akiyoshi K; Kiyono H
Infect Immun; 2013 May; 81(5):1625-34. PubMed ID: 23460513
[TBL] [Abstract][Full Text] [Related]
8. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
Li B; Chen X; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Wu Y
Microb Pathog; 2018 Oct; 123():115-119. PubMed ID: 29959043
[TBL] [Abstract][Full Text] [Related]
9. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines protects mice against invasive pneumococcal infections.
Jakobsen H; Saeland E; Gizurarson S; Schulz D; Jónsdóttir I
Infect Immun; 1999 Aug; 67(8):4128-33. PubMed ID: 10417183
[TBL] [Abstract][Full Text] [Related]
11. Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Haemophilus influenzae after intranasal immunization with outer membrane protein P6 and cholera toxin.
Hotomi M; Saito T; Yamanaka N
Vaccine; 1998 Dec; 16(20):1950-6. PubMed ID: 9796049
[TBL] [Abstract][Full Text] [Related]
12. Induction of Mucosal IgA-Mediated Protective Immunity Against Nontypeable
Nakahashi-Ouchida R; Mori H; Yuki Y; Umemoto S; Hirano T; Uchida Y; Machita T; Yamanoue T; Sawada SI; Suzuki M; Fujihashi K; Akiyoshi K; Kurono Y; Kiyono H
Front Immunol; 2022; 13():819859. PubMed ID: 35874779
[TBL] [Abstract][Full Text] [Related]
13. Mucosal immune features to phosphorylcholine by nasal Flt3 ligand cDNA-based vaccination.
Baatarjav T; Kataoka K; Gilbert RS; Terao Y; Fukui M; Goto M; Kawabata S; Yamamoto M; Fujihashi K; Ito HO
Vaccine; 2011 Aug; 29(34):5747-57. PubMed ID: 21683111
[TBL] [Abstract][Full Text] [Related]
14. Understanding host immune responses to pneumococcal proteins in the upper respiratory tract to develop serotype-independent pneumococcal vaccines.
Lagousi T; Basdeki P; De Jonge MI; Spoulou V
Expert Rev Vaccines; 2020 Oct; 19(10):959-972. PubMed ID: 33107359
[No Abstract] [Full Text] [Related]
15. Serotype-independent protection against pneumococcal infections elicited by intranasal immunization with ethanol-killed pneumococcal strain, SPY1.
Xu X; Meng J; Wang Y; Zheng J; Wu K; Zhang X; Yin Y; Zhang Q
J Microbiol; 2014 Apr; 52(4):315-23. PubMed ID: 24682994
[TBL] [Abstract][Full Text] [Related]
16. Broad protective immune responses elicited by bacterium-like particle-based intranasal pneumococcal particle vaccine displaying PspA2 and PspA4 fragments.
Lu J; Guo J; Wang D; Yu J; Gu T; Jiang C; Kong W; Wu Y
Hum Vaccin Immunother; 2019; 15(2):371-380. PubMed ID: 30235046
[TBL] [Abstract][Full Text] [Related]
17. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
18. Intranasal Immunization with the Commensal
Shekhar S; Khan R; Schenck K; Petersen FC
Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
[No Abstract] [Full Text] [Related]
19. Combined prime-boost immunization with systemic and mucosal pneumococcal vaccines based on Pneumococcal surface protein A to enhance protection against lethal pneumococcal infections.
Zhang Y; Guo X; Guo M; Chen X; Li B; Yu J; Gu T; Kong W; Wu Y
Immunol Res; 2019 Oct; 67(4-5):398-407. PubMed ID: 31773490
[TBL] [Abstract][Full Text] [Related]
20. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
Xu JH; Dai WJ; Chen B; Fan XY
Scand J Immunol; 2015 Mar; 81(3):177-85. PubMed ID: 25565478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
